In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

General Electric

http://www.ge.com

Latest From General Electric

EMA Doubles Number Of EU Early Access Approval Recommendations

The EU’s special provisions for speeding new products towards approval proved more popular than ever with drug sponsors last year.

Europe Approvals

Sawai Lines Up Eight Launches In Japan

Sawai is lining up eight launches as part of the Japanese company’s strategy to capture an increased share of its domestic generics market.

Launches Generic Drugs

Blueprint Prepares To Take On Novartis In Advanced Systemic Mastocytosis

The company’s rollout plans for Ayvakit appear similar to its approach when it marketed the drug for GIST, with an education plan to help boost sales.

Advertising, Marketing & Sales Business Strategies

Medicaid Programs Should Be Able To ‘Compel’ Value-Based Contracts, State Association Official Says

Existing value-based contracts, which are voluntary for manufacturers, do not lower costs for states, National Association of Medicaid Directors executive director Matt Salo suggests.

Pricing Debate Medicaid
See All

Company Information

  • Industry
  • Diversified
  • Medical Devices
  • Other Names / Subsidiaries
    • Amersham
    • Clarient Inc.
    • Asymptote Limited
    • GE Healthcare
    • GE Medical Systems LLC
    • Monica Healthcare
    • Novia Strategies
    • Vital Signs.
    • Xcellerex
    • U-Systems
    • Zionexa SAS
UsernamePublicRestriction

Register